Nandrolone decanoate is an injectable anabolic androgenic steroid. It is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass. Nandrolone cannot be reduced by 5-alpha reductase into DHT and therefore does not have an adverse reaction on the prostate. Instead of DHT, nandrolone metabolizes into dihydronandrolone
Nandrololone does not convert into estrogens. Nandrolone binds well to androgen receptors and also possesses non-receptor mediated stimulation on muscle growth. Nandrolone decanoate is one of the most potent anabolic steroid sfor muscle growth with an excellent myotrophic activity index 3.29 4.92. Nandrolone up-regulates androgen receptor AR expression in skeletal muscle, thus potentiating the actions of other steroids. Nandrolone does not have alkylation on the 17-carbon and therefore is not toxic for the liver
|EACH ML CONTAINS:|
Dosage and administration:
Half life 6 days
Adult dose (Male) 300mg-900mg EOD intramuscular injection.
Adult dose (Female) 25mg-100mg EOD intramuscular injection.
Average Cycle Length: 4-12weeks following an EOD, ETD or EFD injection pattern
Anabolic #: 125
Androgenic #: 37
Bioavailability: Estimated at 100%
CAS Name: (17b)-17-Hydroxyestr-4-en-3-o
Synonyms: Nandrolone, Deca Durabolin, Deca, Eubolin
Hematologic: Suppression of clotting factors II, V, VII, and X, bleeding in patients on concomitant anticoagulant therapy, and polycythemia. Androgens are contraindicated in men with carcinomas of the breast or with known or suspected carcinomas of the prostate and in women who are or may become pregnant.